Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

LMT-28

Copy Product Info
😃Good
Hot
Catalog No. T15769Cas No. 1239600-18-0

LMT-28 is an inhibitor of IL-6 and selectively inhibits IL-6-induced phosphorylation of gp130, STAT3, and JAK2.

LMT-28

LMT-28

Copy Product Info
😃Good
Hot
Purity: 97.55%
Catalog No. T15769Cas No. 1239600-18-0
LMT-28 is an inhibitor of IL-6 and selectively inhibits IL-6-induced phosphorylation of gp130, STAT3, and JAK2.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$37-In Stock
5 mg$55In StockIn Stock
10 mg$97In StockIn Stock
25 mg$212-In Stock
50 mg$333-In Stock
100 mg$487-In Stock
1 mL x 10 mM (in DMSO)$61-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:97.55%
Appearance:Liquid
Color:Transparent
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
LMT-28 is an inhibitor of IL-6 and selectively inhibits IL-6-induced phosphorylation of gp130, STAT3, and JAK2.
In vitro
LMT-28 (1-10000 nM) inhibits IL-6-induced cell proliferation(IC50 = 7.5 μM)[1].
In vivo
In male DBA/1J collagen-induced arthritis mice, LMT-28 (0-0.5 mg/kg) reduces the serum levels of cartilage oligomeric matrix protein, serum amyloid P and anti-CII IgG by 50%, 55%, and 62%[1].
Chemical Properties
Molecular Weight311.42
FormulaC17H29NO4
Cas No.1239600-18-0
SmilesCCCCCC(=C)[C@@H](O)[C@H](C)C(=O)N1[C@H](COC1=O)C(C)C
Relative Density.1.065 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 145 mg/mL (465.61 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (6.42 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2111 mL16.0555 mL32.1110 mL160.5549 mL
5 mM0.6422 mL3.2111 mL6.4222 mL32.1110 mL
10 mM0.3211 mL1.6055 mL3.2111 mL16.0555 mL
20 mM0.1606 mL0.8028 mL1.6055 mL8.0277 mL
50 mM0.0642 mL0.3211 mL0.6422 mL3.2111 mL
100 mM0.0321 mL0.1606 mL0.3211 mL1.6055 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy LMT-28 | purchase LMT-28 | LMT-28 cost | order LMT-28 | LMT-28 chemical structure | LMT-28 in vivo | LMT-28 in vitro | LMT-28 formula | LMT-28 molecular weight